Transcarent
PrivateLast Round
M&A
Apr 8, 2025
Est. Valuation
$2.2B
Total Funding Raised
$424M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Transcarent is a healthtech company that provides a consumer-directed health and care platform for employees of self-insured employers and their families.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Healthcare Analytics, NLP & Conversational AI, Revenue Cycle
Business Model
B2B2C
Customer Profile
Revenue Share, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Transcarent Comparables
Compare Transcarent with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Garner Health | 87% | |
| Included Health | 86% | |
| Quantum Health | 83% | |
Transcarent Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | Apr 8, 2025 | ||||
| Series D | May 2, 2024 | ||||
| Series C | Jan 11, 2022 | ||||
| Series B | Jun 10, 2021 | ||||
| Series A | Oct 22, 2020 |
Key People
Founding team and executive leadership
Transcarent Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Human Capital | Series D, Series C |
| GreatPoint Ventures | Series C, Series B |
| Geodesic Capital | Series D |
| Threshold Ventures | Series C, Series B, Series D |
| Ally Bridge Group | Series C, Series D |
| M13 | Series C, Series B |
| GreatPoint Ventures | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2026
Grew 23% QoQ, from 640 to 786 employees.
- Apr 24, 2026
Partnered with SmithRx to expand Pharmacy Care Experience.
Transcarent Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Transcarent's valuation, stock price, and market status.